Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
TSE/TYO:4512
Wakamoto Pharmaceutical Co., Ltd. (4512) Stock Price & Analysis
0 Followers
4512 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥186.50 - ¥277.00
Previous Close¥253
Volume55.70K
Average Volume (3M)65.95K
Market Cap
¥8.78B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)80.6
Beta0.29
Next Earnings
Aug 02, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2024Dividend Yield1.2%
Share Statistics
EPS (TTM)3.14
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume65,948
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.06% Other Institutional Investors
99.94% Public Companies and
Individual Investors
4512 FAQ
What was Wakamoto Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Wakamoto Pharmaceutical Co., Ltd. lowest stock price was ¥186.50 and its highest was ¥277.00 in the past 12 months.
What is Wakamoto Pharmaceutical Co., Ltd.’s market cap?
Currently, no data Available
When is Wakamoto Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Wakamoto Pharmaceutical Co., Ltd.’s upcoming earnings report date is Aug 02, 2024 which is in 14 days.
How were Wakamoto Pharmaceutical Co., Ltd.’s earnings last quarter?
Wakamoto Pharmaceutical Co., Ltd. released its earnings results on May 15, 2024. The company reported ¥9.06 earnings per share for the quarter, beating the consensus estimate of N/A by ¥9.06.
Is Wakamoto Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Wakamoto Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Wakamoto Pharmaceutical Co., Ltd. pay dividends?
Wakamoto Pharmaceutical Co., Ltd. pays a Annually dividend of ¥3 which represents an annual dividend yield of 1.2%. See more information on Wakamoto Pharmaceutical Co., Ltd. dividends here
What is Wakamoto Pharmaceutical Co., Ltd.’s EPS estimate?
Wakamoto Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wakamoto Pharmaceutical Co., Ltd. have?
Wakamoto Pharmaceutical Co., Ltd. has 34,838,326 shares outstanding.
What happened to Wakamoto Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Wakamoto Pharmaceutical Co., Ltd. reported an EPS of ¥9.06 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.11%.
Which hedge fund is a major shareholder of Wakamoto Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4512
---
Wakamoto Pharmaceutical Co., Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technical Analysis
---